Sign Out
Hypersensitivity to the cytarabine or to any of the excipients of cytarabine injection.
Anaemia, leucopenia and thrombocytopenia of non-malignant aetiology (e.g bone marrow aplasia); unless the clinician feels that such management offers the most hopeful alternative for the patient.
Degenerative and toxic encephalopathies, especially after the use of methotrexate or treatment with ionizing radiation.
Continue with Google